Effect of Concurrent Metformin on Adherence to and Persistence of Treatment With Second-Generation Antipsychotics in Nondiabetic Patients
The Journal of Clinical Psychiatry · 2025
DOI: 10.4088/jcp.25m15808 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, 2025. Verfasst von Jerusha Daggolu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, Texas. Hauptthemen laut MEDLINE: Metformin, Antipsychotic Agents, Hypoglycemic Agents, Medication Adherence.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, Texas.
- Corresponding Author: Hua Chen, MD, PhD, Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Health and Biomedical Sciences, Building 2, Room 4049, 4849 Calhoun Rd, Houst…
Zitieren
APA
Daggolu, J., & Chen, H. (2025). Effect of Concurrent Metformin on Adherence to and Persistence of Treatment With Second-Generation Antipsychotics in Nondiabetic Patients. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.25m15808
Vancouver
Daggolu J, Chen H. Effect of Concurrent Metformin on Adherence to and Persistence of Treatment With Second-Generation Antipsychotics in Nondiabetic Patients. The Journal of Clinical Psychiatry. 2025. doi:10.4088/jcp.25m15808
BibTeX
@article{Daggolu2025,
author = {Daggolu, Jerusha and Chen, Hua},
title = {Effect of Concurrent Metformin on Adherence to and Persistence of Treatment With Second-Generation Antipsychotics in Nondiabetic Patients},
journal = {The Journal of Clinical Psychiatry},
year = {2025},
doi = {10.4088/jcp.25m15808}
}
EUVIMED